The list below shows The Lymphoma Group's current clinical trials open for recruitment for rare lymphomas such as:
- Mantle cell lymphoma
- Burkitt's lymphoma
- MALToma (Marginal zone) lymphoma
- CNS (brain) lymphoma
- Waldenström macroglobulinemia
If you would like to know how to access our trials, please see how to contact us.
- GEN3013 - Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non Hodgkin lymphoma
Suitable for patients with mantle cell, marginal zone and other B cell Non Hodgkin lymphomas
- JCAR017 - Phase 2 study determining efficacy and safety of JCAR017.
Suitable for patients with PCNSL, CNS involved lymphoma, Richter's transformation, and DLBCL which has come back after previous treatment
With special thanks to the following: